Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial Alfons JM van den Eertwegh , Jurjen Versluis , H. Pieter van den Berg +15 more 2012 The Lancet Oncology 355 citations